Aurobindo Pharma
Aurobindo Pharma acquires Portuguese firm for Rs970 crore
09 January 2017
Aurobindo Pharma to buy some commercial products from Teva
26 November 2016
Aurobindo, Intas in race for Teva's Irish generics business
29 August 2016
Aurobindo Pharma mulls bidding for Teva Pharmaceutical’s $1.5 bn drug portfolio
05 July 2016
Aurobindo Phrma to set up plant in S Arabia
11 January 2016
Aurobindo Pharma receives US FDA Approval for Norethindrone Acetate Tablets
11 January 2016
Aurobindo gets US FDA nod to market injectable form of Warner Chilcot’s Actonel tablets
03 December 2015
3 Indian firms get FDA nod to sell generic hypertension drug
07 January 2015
Aurobindo Pharma completes $132.5-m acquisition of US firm Natrol
06 December 2014
Aurobindo Pharma to buy US nutritional supplement maker Natrol for Rs 813 crore
12 November 2014
Aurobindo Pharma to acquire Actavis’s European operations
18 January 2014
Aurobindo Pharma rejigs execs in wake of ‘Jagan scam’
31 May 2012
Aurobindo Pharma in generic drugs JV with Russia's Diod
07 September 2011
Aurobindo receives USFDA approval for Alprazolam extended-release tablets
08 June 2011
Sinopharm to acquire 80-% stake in Aurobindo's China subsidiary
11 January 2011
Aurobindo Pharma receives USFDA approvals for Ampicillin for Injection
23 August 2010
Aurobindo Pharma epilepsy drug gets Canadian approval
22 March 2010
Aurobindo Pharma's antibiotic ANDA gets Canadian approval
03 March 2010
Aurobindo gets US FDA nod for 50mg dosage of HIV drug `Nevirapine'
26 February 2010
Aurbindo to merge subsidiary Trident Life Sciences Ltd
13 November 2009
Aurobindo Pharma receives USFDA, Swissmedic approval for drugs
07 September 2009
Aurobindo Pharma to acquire Trident Life Sciences
17 August 2009
Aurobindo wins FDA nod for generic drug
08 August 2009
Aurobindo gets Australian nod for cholesterol pills
11 May 2009
Aurobindo's HIV drug, Ranbaxy's epillepsy drug get USFDA nod
01 April 2009
Pfizer ties up with Aurobindo for generic drugs
04 March 2009
Pfizer acquires rights to several generics from Aurobindo
03 March 2009
Aurobindo Pharma gets USFDA nod for anti-HIV drug
22 December 2008
Eli Lilly sues Lupin, Aurobindo for patent infringement
03 December 2008
Aurobindo acquires Italian generic pharma firm TAD
24 March 2008
Aurobindo Pharma gets US approval to sell generic Omnicef
19 December 2007
Aurobindo Pharma receives five product approvals from USFDA including two Paragraph IV products
24 November 2007
Aurobindo Pharma rules out stake sale
13 June 2007
Aurobindo Pharma acquires Dutch company
30 December 2006
Aurobindo receives approval for AIDS drug
22 December 2006
Aurobindo Pharma divests stake in Chinese subsidiary
15 November 2006
US FDA approves Aurobindo Pharma''s Meloxicam for US sales
06 October 2006
Aurobindo betalactum facility receives MCC South Africa's approval
28 August 2006
Aurobindo gets marketing approval for mirtazapine tablets in UK
18 August 2006
Aurobindo gets second MHRA approval in UK for mirtazapine tablets
09 August 2006
Aurobindo receives US FDA approval for 3-in-1 ARV combination
03 July 2006
Bristol-Myers grants ARV license for two drugs to Aurobindo Pharma
17 March 2006
Aurobindo receives first NDA approval for HIV-1 drug from US FDA
16 March 2006
Update: US FDA nod for Aurobindo''s Lisinopril & Hydrochlorothiazide tabs
16 March 2006
Aurobindo Pharma receives final US FDA approval for Mirtazapine ODT 45mg
02 March 2006
Aurobindo receives UK MHRA approval
20 January 2006
US FDA grants tentative approval to Aurobindo''s anti-AIDS drug for children
23 December 2005
Aurobindo Pharma selected for IDMA''s patents appreciation award.
15 December 2005
Final US FDA approval for Aurobindo''s Mirtazapine oral disintegrating tablets
14 December 2005
Aurobindo Pharma''s anti-AIDS drug selected by WHO
12 December 2005
Aurobindo Pharma plans to raise funds from global markets
06 July 2005
Templeton Strategic acquires 2.9 per cent stake in Aurobindo Pharma
08 May 2004
FIIs hike stake in Lupin, Cadila Healthcare, Aurobindo Pharma
20 October 2003
Aurobindo Pharma to invest Rs 50 crore for R&D centre in Mumbai
29 July 2003
Aurobindo buys 80% in Ranit Pharma
05 April 2002
Aurobindo Pharma launches Cefactam
20 February 2002
Aurobindo launches Cefpirome
07 February 2002
Templeton to buy Aurobindo shares
26 December 2001
Templeton subscribes to Aurobindo shares
19 December 2001
Aurobindos mega overseas plans
15 December 2001
Aurobindo turns cold on Dee Pharma unit
24 April 1999
 search domain-b